Irinquiries@prestigebrands.com
Prestige Consumer Healthcare Inc.
660 White Plains Road – Ste 250
Tarrytown, NY 10591
Telephone: 914-524-6819
As filed with the Securities and Exchange Commission on May 15, 2019
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
to
FORM S-8
REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
Prestige Consumer Healthcare Inc. |
(Exact name of registrant as specified in its charter) |
Delaware | 20-1297589 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
660 White Plains Road Tarrytown, New York 10591 |
(Address of Principal Executive Offices and Zip Code) |
Prestige Consumer Healthcare Inc. 2005 Long-Term Equity Incentive Plan |
(Full title of the plan) |
William P’Pool Prestige Consumer Healthcare Inc. General Counsel, Senior Vice President, and Corporate Secretary 660 White Plains Road Tarrytown, New York 10591 (914) 524-6800 |
(Name, address and telephone number, including area code, of agent for service) |
Copy to:
Sarah E. Ernst
Alston & Bird LLP
One Atlantic Center
1201 W. Peachtree Street
Atlanta, GA 30309
(404) 881-7000
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer | x | Accelerated Filer | ¨ | |||
Non-accelerated filer | ¨ | Smaller reporting company | ¨ | |||
Emerging growth company | ¨ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. o
EXPLANATORY NOTE
This Post-Effective Amendment No. 1 relates to the following registration statement (the “Registration Statement”) filed with the Securities and Exchange Commission on March 22, 2005 by Prestige Consumer Healthcare Inc., a Delaware corporation (the “Registrant”):
• | Registration Statement filed on Form S-8, File No. 333-123487, registering 5,000,000 shares of common stock, par value $0.01 per share, for issuance under the Registrant’s 2005 Long-Term Equity Incentive Plan. |
This Post-Effective Amendment No. 1 to the Registration Statement is being filed solely for the purpose of refiling Exhibit 23.2 thereto, to add a signature to the Consent of Independent Registered Public Accounting Firm. All other portions of the Registration Statement, as previously filed, remain unchanged. No additional securities are to be registered, and registration fees were paid upon filing of the original Registration Statement.
Item 8. | Exhibits. |
*Incorporated by reference.
SIGNATURES
Pursuant to the requirements of the Securities Act, the Company certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Tarrytown, State of New York, on May 15, 2019.
PRESTIGE CONSUMER HEALTHCARE INC. | ||
By: | /s/ Ronald M. Lombardi | |
Name: | Ronald M. Lombardi | |
Title: | President and Chief Executive Officer |
Pursuant to the requirements of the Securities Act, this registration statement has been signed by the following persons in the capacities and on the dates indicated.
Signature | Title | Date | |||
/s/ Ronald M. Lombardi Ronald M. Lombardi |
Director, President and Chief Executive Officer (Principal Executive Officer) |
May 15, 2019 | |||
/s/ Christine Sacco Christine Sacco |
Chief Financial Officer (Principal Financial and Principal Accounting Officer) |
May 15, 2019 | |||
/s/ John E. Byom John E. Byom |
Director | May 15, 2019 | |||
/s/ Gary E. Costley Gary E. Costley |
Director | May 15, 2019 | |||
/s/ Sheila A. Hopkins Sheila A. Hopkins |
Director |
May 15, 2019 | |||
/s/ Carl J. Johnson Carl J. Johnson |
Director | May 15, 2019 | |||
/s/ James M. Jenness James M. Jenness
|
Director | May 15, 2019 | |||
/s/ Natale S. Ricciardi Natale S. Ricciardi |
Director | May 15, 2019 |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-8 of Prestige Consumer Healthcare Inc. of our report dated May 13, 2019 relating to the financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in Prestige Consumer Healthcare Inc.’s Annual Report on Form 10-K for the year ended March 31, 2019.
/s/ PricewaterhouseCoopers LLP
Stamford, Connecticut
May 15, 2019